• Thurs news: Novartis not joining weight loss race. Pharma marketing and climate change. Roche flu treatment trial. Cercle’s fund raise for women’s health. ICER looks at GSK COPD drugs. See more on our front page

ACC: Bayer and Merck’s vericiguat leads off virtual meeting with positive phase 3 heart...

cafead

Administrator
Staff member
  • cafead   Mar 28, 2020 at 11:42: PM
via After teasing positive top-line results last November, a deeper dive into Merck & Co. and Bayer’s heart failure drug vericiguat helped kick off this year’s scientific meeting of the American College of Cardiology, presented virtually as a late-breaking trial.

article source
 

<